![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 51, 36052-36057, December 17, 1999
,
,From the Department of Molecular Genetics, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
| |
ABSTRACT |
|---|
|
|
|---|
The p21-activated kinase (PAK) homolog Shk1 is
essential for cell viability in the fission yeast
Schizosaccharomyces pombe. Roles have been established for
Shk1 in the regulation of cell morphology, sexual differentiation, and
mitosis in S. pombe. In this report, we describe the
genetic and molecular characterization of a novel SH3 domain protein,
Skb5, identified as a result of a two-hybrid screen for Shk1
interacting proteins. S. pombe cells carrying a deletion of
the skb5 gene exhibit no discernible phenotypic defects
under normal growth conditions, but when subjected to hypertonic
stress, become spheroidal in shape and growth impaired. Both of these
defects can be suppressed by overexpression of the Shk1 modulator,
Skb1. The growth inhibition that results from overexpression of Shk1 in
S. pombe cells is markedly suppressed by a null mutation in
the skb5 gene, suggesting that Skb5 contributes positively
to the function of Shk1 in vivo. Consistent with this notion, we show that Skb5 stimulates Shk1 catalytic function in S. pombe cells. Furthermore, and perhaps most
significantly, we show that bacterially expressed recombinant Skb5
protein directly stimulates the catalytic activity of recombinant Shk1
kinase in vitro. These and additional data described herein
demonstrate that Skb5 is a direct activator of Shk1 in fission yeast.
p21-activated kinases
(PAKs)1 comprise a highly
conserved family of serine/threonine kinases that are regulated by the
p21 G proteins Cdc42 and Rac, but not by other small G proteins, such as Ras and Rho (1). PAKs share a common structural organization consisting of a C-terminal catalytic domain and a substantial N-terminal regulatory domain that typically comprises at least half the
length of the protein. The p21-binding site is invariably located in
the N-terminal regulatory domain of PAKs. Diverse functions have been
attributed to PAKs in eukaryotic organisms, including roles in
regulation of cytoskeletal organization and cellular morphology (2-5),
growth factor-induced signaling pathways (2, 6-8), and cell cycle
control (9-11) in organisms ranging from yeasts to mammals and cell
motility (1), neurological function (12), and apoptosis (9, 13) in
vertebrates. Indeed, the biological functions attributed to PAKs in
eukaryotes match or exceed those attributed to the similarly conserved
mitogen-activated protein kinase cascades, with which, in some cases,
PAKs have been shown to functionally interact (6, 8, 14).
The fission yeast Schizosaccharomyces pombe possesses two
known PAKs, Shk1 (2) (also known as Pak1 (3) and Orb2 (11)) and Shk2
(15) (also known as Pak2 (16)). Shk1 is essential for viability of
S. pombe cells and has been shown to play roles in the
regulation of cell morphology, sexual differentiation, and mitosis (2,
3, 10, 11, 17). The cellular functions of Shk1 are virtually
indistinguishable from those of Cdc42 (2, 18, 19), and various
molecular and genetic data suggest that Shk1 is a critical effector for
Cdc42 in fission yeast (2, 3, 15). A second positive modulator of Shk1,
Skb1, was identified by our laboratory from a two-hybrid screen for
Shk1-interacting proteins (17). Skb1 functions as a
dosage-dependent mitotic inhibitor in S. pombe,
and this function is at least partially dependent on Shk1 (10). Unlike
Shk1 and Cdc42, Skb1 is not required for viability or mating of
S. pombe cells (17). The second known fission yeast PAK,
Shk2, is also nonessential, and genetic analyses suggest that it is
largely redundant in function with Shk1 (15, 16).
In this report, we describe the genetic and molecular characterization
of skb5 (for Shk1 kinase
binding protein 5), a gene encoding a novel SH3
domain protein that interacts with Shk1 in vivo and in
vitro. We present genetic evidence for functional interaction
between Skb5 and Shk1 in S. pombe and biochemical evidence
that Skb5 is a direct stimulator of Shk1 catalytic function. Our
results provide what is to our knowledge the first example of direct
activation of a PAK by an SH3 domain protein.
Yeast Strains, Manipulation, Genetic Analyses, and Two-hybrid
Assays--
S. pombe strains used in this study were SP870
(h90 ade6-210 leu1-32 ura4-D18)
(from D. Beach), SP870D (h90 ade6-210
leu1-32 ura4-D18/h90 ade6-210 leu1-32
ura4-D18) (from V. Jung), CHP428 (h+
ade6-210 his7-366 leu1-32 ura4-D18) (from E. Chang), SP42N17 (h90 ade6-216 leu1-32
ura4::adh1-cdc42N17) (2), SPSKB5U
(h90 ade6-210 leu1-32 ura4-D18
skb5::ura4) (see below), 137 (h Plasmids--
The two-hybrid plasmids pGADGH (for expression of
GAD fusions) and pBTM116 and pVJL11 (for expression of LBD fusions)
have been described previously (19, 20, 23, 24). The plasmids pLBDShk1,
pLBDShk1 (308-658), pLBDRas1, pGADGHByr2, and pLBDlamin have also been
described before (2, 17, 19, 24). The S. pombe-Escherichia
coli shuttle vector pAAUCM and pART1CM were used for high level
expression of coding sequences from the S. pombe adh1
promoter (2). pREP1 (25) was used for expressing coding sequences from
the S. pombe nmt1 promoter. pAAUCMShk1, pAAUCMShk1 Kinase Assays and Coprecipitation Experiments--
For kinase
assays and coprecipitation experiments using proteins purified from
S. pombe cell lysates, S. pombe cells expressing GST fusion proteins, either alone or in combination with CMSkb5, were
grown in EMM to about 107 cells/ml, washed with yeast lysis
buffer, and resuspended in yeast lysis buffer before lysing using glass
beads as described previously (15). GST fusion proteins were
precipitated from yeast cell lysates using glutathione-agarose beads as
recommended by the manufacturer (Amersham Pharmacia Biotech). For
coprecipitation experiments, immunoblots were performed as described
previously using anti-GST antibody (Pierce) and anti-c-Myc antibody
9E10 (27). Kinase assays of purified GST proteins were carried out at
30 °C in 25 µl of kinase buffer A (50 mM Tris-HCl, pH
7.5, 100 mM NaCl, 10 mM MgCl2, and
1 mM MnCl2, 0.1 µg/µl MBP, 50 µM ATP, 10 µCi of [
GST and GST-Skb5 were purified from bacterial lysates using
glutathione-agarose following the manufacturer's recommendations (Amersham Pharmacia Biotech), except that protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 µM
pepstatin A, 50 µg/ml leupeptin, 36 µg/ml E-64, 10 µg/ml
aprotinin) were used in the lysis buffer. Bacterial cells expressing
His6-Shk1 were lysed by sonication in lysis buffer B (50 mM NaF, 10 mM Na3VO4,
10 mM C3H7O6PNa2, 137 mM NaCl, 50 mM Tris-HCl, pH 7.5, 1% Nonidet
P-40, and 10% glycerol), while His6-Ha-Ras cultures were
lysed in lysis buffer C (10 mM MgCl2, 150 mM NaCl, and 50 mM Tris-HCl, pH 7.5 10%,
glycerol, and 0.5% dodecyl- We previously described a two-hybrid screen for identification of
Shk1-interacting proteins (17). Partial cDNAs corresponding to two
distinct S. pombe genes were identified as a result of this
screen, skb1, which has been described previously (17), and
skb5 (previously referred to as skb2 (17)), which
we describe in this report. The full-length skb5 gene was
cloned by a hybridization screen of an S. pombe genomic
library. Sequence analysis revealed that the skb5 gene
(GenBankTM accession number AF192549) contains an
uninterrupted open reading frame encoding a small protein, 140 amino
acids in length, with a predicted molecular mass of approximately 16 kDa (Fig. 1A). The Skb5
protein contains a single C-terminal SH3 domain (amino acids 87-136)
and a highly acidic N terminus. BLAST searches of the nucleic acid and
protein sequence data bases revealed that Skb5 shares structural
homology with an unpublished S. cerevisiae protein, Nbp2
(35% overall identity), and an alternative, non-tyrosine kinase
product, c-Scr, encoded by the chicken c-src gene (28) (26%
identity) (Fig. 1B). The SH3 domain of Skb5 is 50%
identical with the SH3 domain of Nbp2 and 36% identical with the SH3
domain of c-Scr. We determined that the SH3 domain of Skb5 is both
necessary and sufficient for interaction with Shk1 in the two-hybrid
system (Table I). N- and C-terminal
deletion mutants of Shk1 were used to determine that Skb5 interacts
with the N-terminal regulatory domain of Shk1 (Table I). This result
suggested that Skb5 might be a Shk1 regulator.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
leu1-32 ura4-D18 wee1::ura4). The Saccharomyces
cerevisiae two-hybrid tester strain used was L40 (MATa
ade2 his3 leu2 trp1 LYS2::lexA-HIS3 URA3::lexA-lacZ) (20). Standard yeast culture media and
genetic methods were used (21, 22). S. pombe cultures were
grown on either rich medium (YEA) or synthetic minimal medium (EMM)
with appropriate auxotrophic supplements (21). S. cerevisiae
cultures were grown on either rich medium (YPD) or drop-out medium (DO) with appropriate auxotrophic supplements (22). Yeast were transformed by the lithium acetate procedure (22). The
skb5::ura4 strain SPSKB5U was constructed by
transformation of SP870D with a 2.6-kb NdeI
skb5::ura4 fragment from the plasmid
pBSIISkb5::ura4. Diploid transformants carrying a single
disrupted and a single wild-type copy of skb5 were
identified by Southern blot analysis and
skb5::ura4 transformants were isolated by tetrad
dissection. The liquid assay for
-galactosidase activity was
performed as described previously (22).
N118,
pART1CMShk1
N118, pART1CMShk1, pAAUGSTShk1, and pAAUGSTShk1
N118
have been described previously (2, 10, 17). pTrcHis-Ha-Ras has also
been described previously (26). pTrcHisShk1 was made by cloning
BamHI-SalI fragment of Shk1 into the
BamHI-XhoI sites of pTrcHisB. The polymerase
chain reaction was used to amplify the full-length skb5
protein coding sequence for cloning into pAAUCM, pART1CM, pREP1,
pGADGH, and pRP259, producing pAAUCMSkb5, pART1CMSkb5, pREP1Skb5,
pGADGHSkb5, and pRP259Skb5, respectively. The primer pair SKB5KOP3
(5'-GAAGCTTCAGGAAGAAGCG) and SKB5KOP6 (5'-CAGGCTCGAGAATGTCCATTATTCGTGATCA) was used to amplify a 0.95-kb fragment of the 3'-end of skb5. This fragment was then
digested with HindIII and EcoRV and cloned into
HindIII and HincII sites of pBluescriptII,
producing pBSIIskb5-3. The primer pair SKB5KOP7 (5'-ACTATATGGTGGAGCTCAGTGCAA) and SKB5KOP2
(5'-ACACAAGCTTCAATCACACGAGCAT) was used to amplify a 0.8-kb fragment of
the 5'-end of skb5, which was digested with SacI
and HindIII and cloned into the corresponding sites of
pBSIIskb5-3 generating pBSIIskb5KO. This pBSIIskb5KO was digested with
HindIII and ligated with a 1.8-kb HindIII
fragment of the ura4 gene to produce
pBSIIskb5::ura4. Shk1 (1-380) and Skb5 (1-88) protein
coding sequences were both obtained by polymerase chain reaction and
then cloned into pVJL11 and pGADGH, respectively, generating pVJL11Shk1
(1-380) and pGADGHSkb5 (1-88).
-32P]ATP (6,000 Ci/mmol)). Reactions were terminated after 20 min by adding 4 × SDS-PAGE sample buffer (Novex) and boiling for 5 min. Assays were
resolved by SDS-PAGE and subsequent autoradiography.
-D-maltoside (Calbiochem).
His6-tagged proteins were purified using nickel-agarose
beads following the manufacturer's instructions (Invitrogen). Proteins
were concentrated and exchanged into storage buffer (20 mM
HEPES, pH 7.5, 100 mM NaCl, 2 mM
MgCl2, 1 mM dithiothreitol) using Centriprep-5
concentrators (Millipore). Kinase assays were performed at 30 °C in
kinase buffer B (50 mM HEPES, pH 7.4, 10 mM
MgCl2, 2 mM MnCl2, 1 mM
dithiothreitol, 0.05% Triton X-100, 0.04 µg/µl MBP, 20 µM ATP, 10 µCi of [
-32P]ATP (6,000 Ci/mmol)). Reactions were terminated after 20 min by addition of 4 × SDS-PAGE sample buffer (Novex) and boiling for 5 min prior to
resolving on a 4-15% SDS-PAGE gradient gel (Bio-Rad) and subsequent autoradiography.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (49K):
[in a new window]
Fig. 1.
Sequence analysis of the skb5
gene and alignment of the predicted Skb5 protein with related
proteins from budding yeast and chicken. A, nucleotide
sequence and translation of the skb5 gene. The SH3 domain of
the Skb5 protein is indicated by black boxes with
white text. In-frame stop codons are indicated by the
asterisks. B, alignment of amino acids 1-136 of
Skb5 with amino acids 1-166 of S. cerevisiae Nbp2
(GenBankTM accession number D43693) and 1-137 of chicken
c-Scr. Identical amino acids are indicated by black boxes
with white text and similar amino acids by gray
boxes with black text.
Two-hybrid interactions between Skb5 and Shk1 proteins
-galactosidase activity detected between pairs
of LBD and GAD fusion proteins using the quantitative liquid
-galactosidase assay (see "Experimental Procedures"). The SH3
domain of Skb5 comprises amino acids 87-136. The regulatory domain of
Shk1 comprises amino acids 1-380, while the catalytic domain consists
of amino acids 381-658. Values are expressed as Miller units and
represent the average activity detected for at least two independent
transformants.
Genetic and molecular analyses were performed to establish whether the
interaction between Skb5 and Shk1 is biologically significant. We first
expressed Skb5 as a c-Myc epitope-tagged protein (CMSkb5) in fission
yeast to determine whether it coprecipitates with full-length Shk1, as
well as the original Shk1 two-hybrid bait protein, Shk1
N118, which
were each fused to glutathione S-transferase (GST-Shk1 and GST-Shk1
N118, respectively). Shk1
N118 corresponds to the
originally published Shk1 protein sequence (2), which was truncated by 118 amino acids due to a sequencing error. Shk1
N118 can substitute for full-length Shk1 protein in S. pombe
cells.2 CMSkb5 coprecipitated
with GST-Shk1 and GST-Shk1
N118 from S. pombe cell
lysates, but did not coprecipitate with GST (Fig.
2), demonstrating that Skb5 and Shk1
proteins form a complex in S. pombe.
|
An skb5 null (skb5
) mutation was generated in
which most of the skb5 protein coding sequence was replaced
by the ura4 gene (Fig.
3A). Unlike shk1
mutants, skb5
mutants were viable and exhibited no
obvious phenotypic defects under normal growth conditions in either
rich or minimal media (data not shown). skb5
mutants were
also indistinguishable from wild-type cells when grown at either 20 or
36 °C, indicating that the skb5
mutation does not cause cold or temperature sensitive phenotypes, respectively (data not
shown). Recent studies in our laboratory have demonstrated that Cdc42,
Shk1, and Skb1 are each required for normal response to hypertonic
stress in S. pombe.3 S. pombe mutants expressing a dominant inhibitory mutant allele of
cdc42 are inviable and cells deficient in Shk1 expression
are growth impaired when cultured in hypertonic medium.
skb1
mutants, which are normally only modestly shorter
than wild-type cells, become ellipsoidal in shape when subjected to
hypertonic stress. These observations prompted us to investigate
whether the growth or morphology of skb5
mutants is
affected by hypertonic stress. Indeed, we found that skb5
mutants grew slower than wild-type cells and became ellipsoidal in
morphology when grown in 1.5 M KCl (Fig. 3, B
and C), demonstrating that Skb5, like Cdc42, Shk1, and Skb1,
is required for normal growth and morphology of S. pombe cells in hypertonic medium.
|
Additional genetic analyses were performed to further establish a
functional link between Skb5 and Shk1. We determined that overexpression of Shk1 is significantly less inhibitory to the growth
of skb5
cells than to wild-type cells (Fig.
3D), providing evidence that Skb5 might be required for
normal Shk1 function in S. pombe. We found further that Skb5
overexpression was inhibitory to the growth of S. pombe
cells expressing a dominant inhibitory mutant allele of
cdc42, cdc42T17N, and that this growth defect could be suppressed by overexpression of Shk1
N118 (Fig.
3E). Shk1
N118 was used for this experiment because, for
reasons that at present are unclear, overexpression of full-length Shk1
is highly toxic to cells expressing
Cdc42T17N.4 Interestingly, we
observed that wild-type cells that overexpressed Skb5 were spheroidal
in morphology (data not shown), suggesting that Skb5 overexpression may
have a dominant inhibitory effect with respect to function of the
Cdc42/Shk1 morphological control pathway in S. pombe,
possibly due to sequestration of Shk1 from proper interaction with its
other regulators and/or targets. This idea is consistent with the
observation that overexpression of Skb5 was inhibitory to growth of
cells expressing Cdc42T17N and that overexpression of Shk1
N118 could
suppress this growth defect. Although overexpression of Shk1 could not
suppress hypertonic stress-induced growth or morphological defects of
the skb5
mutant (data not shown), these defects were
suppressed by overexpression of the Shk1 modulator Skb1 (Fig. 3,
B and C). These various genetic data provide
strong evidence that Skb5 and Shk1 interact functionally in S. pombe, with Skb5 possibly functioning as a positive regulator of Shk1.
Biochemical experiments were performed to establish whether Skb5
regulates the catalytic function of Shk1. S. pombe cells expressing GST or GST-Shk1
N118, both with and without
co-overexpression of Skb5, were lysed and GST and GST-Shk1
N118
proteins purified from the resulting cell lysates. Kinase assays were
then performed to measure the ability of GST-Shk1
N118 to both
autophosphorylate and phosphorylate MBP. GST-Shk1
N118 was used for
this experiment, because we found that a GST fusion of the full-length
Shk1 protein was expressed at a substantially higher level in cells
that overexpressed Skb5, making it impossible to obtain meaningful
comparisons of Shk1 kinase activity between cells that overexpressed
Skb5 and cells that did not. As shown in Fig.
4A, the phosphorylation of MBP
by GST-Shk1
N118 was significantly greater for protein isolated from
cells that overexpressed Skb5 than from cells that did not, while
autophosphorylation of GST-Shk1
N118 was only slightly increased for
protein isolated from cells that overexpressed Skb5 (Fig. 4A). No detectable kinase activity was observed for the GST
samples. These results suggest that Skb5 stimulates Shk1 catalytic
activity in vivo and that it might do so without
substantially affecting Shk1 autophosphorylation.
|
We next asked whether Skb5 directly stimulates Shk1 catalytic function by determining whether recombinant Skb5 protein purified from bacterial cells directly stimulates the catalytic function of bacterially expressed Shk1 protein. Skb5 was purified in recombinant form as a GST fusion protein (GST-Skb5), while Shk1 was purified as a polyhistidine-tagged protein (His6-Shk1) (Fig. 4B). GST-Skb5 and His6-Shk1, as well as the control proteins GST and His6-Ha-Ras, were mixed together in various combinations and assayed for kinase activity. Strikingly, we observed that GST-Skb5 strongly stimulated the ability of His6-Shk1 to phosphorylate MBP, but without stimulating Shk1 autophosphorylation (Fig. 4C). This result demonstrates that Skb5 directly stimulates Shk1 catalytic function in vitro. The observed decrease in His6-Shk1 autophosphorylation in the presence of GST-Skb5 (Fig. 4C) was most likely due to substrate competition by MBP, since in assays lacking MBP, GST-Skb5 had no affect on the autophosphorylation of Shk1 (Fig. 4D). In addition to stimulating Shk1 catalytic function, GST-Skb5 was also phosphorylated by Shk1 in vitro (Fig. 4, C and D). We have determined from in vivo labeling experiments that Skb5 is also a phosphoprotein in S. pombe (data not shown); however, we do not yet know whether its in vivo phosphorylation is dependent on Shk1.
In summary, we have described the genetic and molecular
characterization of a novel SH3 domain protein, Skb5, that positively regulates the function of the fission yeast PAK Shk1. Skb5 clearly plays only an auxiliary role in regulating the overall function of
Shk1. While the shk1
mutation is lethal to S. pombe cells, skb5
cells lack any discernible
phenotypic defects under normal growth conditions. Even under
conditions of hypertonic stress, skb5
mutants, while
spheroidal in shape, are only modestly inhibited for growth. It is
possible that Skb5 plays a more significant cellular role under
environmental conditions that we have not tested or that Skb5 is
functionally redundant with another protein(s) (e.g. another
Skb5-related protein). Alternatively, it is conceivable that the proper
regulation of cell morphology under conditions of hypertonic stress
does not represent an essential function of Shk1. Although its cellular
role, as presently defined, is potentially modest, the identification
and characterization of Skb5 is significant, because it represents what
is to our knowledge the first example of an SH3 domain protein capable
of directly stimulating the catalytic activity of a purified PAK.
Previous studies have demonstrated interactions between mammalian PAKs
and SH3 domain proteins, specifically, the SH2/SH3 adaptor protein Nck
(29) and the Cdc42/Rac guanine nucleotide exchange factor proteins
-and
-PIX (30, 31). Nck and PIX proteins are thought to function
in recruiting PAKs to Cdc42 and/or Rac complexes in the cell, where the
PAKs are subsequently activated by the p21 G proteins (29, 30). A
mutated form of PIX lacking its guanine nucleotide exchange factor
domain was capable of stimulating the kinase activity of a PAK immune
complex in vitro, suggesting that PIX also has
Cdc42/Rac-independent PAK stimulatory function (32). However, since
these experiments used PAK immune complexes, they did not provide an
indication of whether PIX function is sufficient to directly stimulate
PAK catalytic function, as other proteins in the immune complex may
have been required for this activity. The founding member of the PAK
family, the budding yeast Ste20 kinase (7, 33), has also been shown to
form a complex with the SH3 domain protein Bem1 (34), although the
functional nature of this interaction has not yet been defined. Based
on these previously described findings and those presented in this report, it is reasonable to speculate that functional regulation by SH3
domain proteins represents a broadly conserved primordial feature of
eukaryotic PAKs that has been modified and reiterated through the
course of evolution to provide multiple mechanisms for PAK activation,
thereby allowing these kinases to regulate numerous and diverse
cellular processes. Moreover, our results raise the exciting
possibility that PAKs in higher organisms might, in some cases, be
directly activated by SH3 domain proteins. This potential alternative
mechanism for PAK activation may ultimately help to explain how PAKs
are functionally regulated such that they can be targeted to perform
the diverse cellular functions to which they have been linked in
eukaryotic organisms.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Ramesh Gadiraju, Mary Gilbreth, and Anjana Kundu for technical assistance; and Anthony Polverino and members of the Marcus laboratory for critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant R01GM53239. DNA sequencing was performed by the University of Texas M. D. Anderson Cancer Center Core DNA Sequencing Facility, which is supported by National Institutes of Health Grant P30CA16672.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF192549 (for skb5).
These authors contributed equally to this work.
§ To whom correspondence should be addressed. Tel.: 713-745-2032; Fax: 713-794-4394; E-mail: smarcus@notes.mdacc.tmc.edu.
2 S. M., unpublished results.
3 P. Yang, R. Pimental, H. Lai, and S. Marcus, manuscript in preparation.
4 P. Yang and S. Marcus, unpublished results.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PAK, p21-activated kinase; kb, kilobase pair; GST, glutathione S-transferase; MBP, myelin basic protein; PAGE, polyacrylamide gel electrophoresis; LBD, LexA DNA binding domain.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Sells, M. A., and Chernoff, J. (1997) Trends Cell Biol 7, 162-167 |
| 2. |
Marcus, S.,
Polverino, A.,
Chang, E.,
Robbins, D.,
Cobb, M. H.,
and Wigler, M. H.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6180-6184 |
| 3. | Ottilie, S., Miller, P. J., Johnson, D. I., Creasy, C. L., Sells, M. A., Bagrodia, S., Forsburg, S. L., and Chernoff, J. (1995) EMBO J. 14, 5908-5919[Medline] [Order article via Infotrieve] |
| 4. | Manser, E., Huang, H. Y., Loo, T. H., Chen, X. Q., Dong, J. M., Leung, T., and Lim, L. (1997) Mol. Cell. Biol. 17, 1129-1143[Abstract] |
| 5. | Sells, M. A., Knaus, U. G., Bagrodia, S., Ambrose, D. M., Bokoch, G. M., and Chernoff, J. (1997) Curr. Biol 7, 202-210 |
| 6. |
Polverino, A.,
Frost, J.,
Yang, P.,
Hutchison, M.,
Neiman, A. M.,
Cobb, M. H.,
and Marcus, S.
(1995)
J. Biol. Chem.
270,
26067-26070 |
| 7. | Leberer, E., Dignard, D., Harcus, D., Thomas, D. Y., and Whiteway, M. (1992) EMBO J. 11, 4815-4824[Medline] [Order article via Infotrieve] |
| 8. | Frost, J. A., Xu, S., Hutchison, M. R., Marcus, S., and Cobb, M. H. (1996) Mol. Cell. Biol. 16, 3707-3713[Abstract] |
| 9. | Faure, S., Vigneron, S., Doree, M., and Morin, N. (1997) EMBO J. 16, 5550-5561[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Gilbreth, M.,
Yang, P.,
Bartholomeusz, G.,
Pimental, R. A.,
Kansra, S.,
Gadiraju, R.,
and Marcus, S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14781-14786 |
| 11. |
Verde, F.,
Wiley, D. J.,
and Nurse, P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7526-7531 |
| 12. | Allen, K. M., Gleeson, J. G., Bagrodia, S., Partington, M. W., MacMillan, J. C., Cerione, R. A., Mulley, J. C., and Walsh, C. A. (1998) Nat. Genet. 20, 25-30[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Rudel, T.,
and Bokoch, G. M.
(1997)
Science
276,
1571-1574 |
| 14. |
Zhang, S.,
Han, J.,
Sells, M. A.,
Chernoff, J.,
Knaus, U. G.,
Ulevitch, R. J.,
and Bokoch, G. M.
(1995)
J. Biol. Chem.
270,
23934-23936 |
| 15. |
Yang, P.,
Kansra, S.,
Pimental, R. A.,
Gilbreth, M.,
and Marcus, S.
(1998)
J. Biol. Chem.
273,
18481-18489 |
| 16. |
Sells, M. A.,
Barratt, J. T.,
Caviston, J.,
Ottilie, S.,
Leberer, E.,
and Chernoff, J.
(1998)
J. Biol. Chem.
273,
18490-18498 |
| 17. |
Gilbreth, M.,
Yang, P.,
Wang, D.,
Frost, J.,
Polverino, A.,
Cobb, M. H.,
and Marcus, S.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13802-13807 |
| 18. |
Miller, P. J.,
and Johnson, D. I.
(1994)
Mol. Cell. Biol.
14,
1075-1083 |
| 19. | Chang, E. C., Barr, M., Wang, Y., Jung, V., Xu, H. P., and Wigler, M. H. (1994) Cell 79, 131-141[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Vojtek, A. B., Hollenberg, S. M., and Cooper, J. A. (1993) Cell 74, 205-214[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Alfa, C., Fantes, P., Hyams, J., McLeod, M., and Warbrick, E. (1993) Experiments with Fission Yeast: A Laboratory Course Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 22. | Rose, M. D., Winston, F., and Hieter, P. (1990) Methods in Yeast Genetics: A Laboratory Course Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 23. |
Van Aelst, L.,
Barr, M.,
Marcus, S.,
Polverino, A.,
and Wigler, M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
6213-6217 |
| 24. |
Marcus, S.,
Polverino, A.,
Barr, M.,
and Wigler, M.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7762-7766 |
| 25. |
Maundrell, K.
(1990)
J. Biol. Chem.
265,
10857-10864 |
| 26. |
Shibuya, E. K.,
Polverino, A. J.,
Chang, E.,
Wigler, M.,
and Ruderman, J. V.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
9831-9835 |
| 27. |
Evan, G. I.,
Lewis, G. K.,
Ramsay, G.,
and Bishop, J. M.
(1985)
Mol. Cell. Biol.
5,
3610-3616 |
| 28. |
Dorai, T.,
and Wang, L. H.
(1990)
Mol. Cell. Biol.
10,
4068-4079 |
| 29. |
Bokoch, G. M.,
Wang, Y.,
Bohl, B. P.,
Sells, M. A.,
Quilliam, L. A.,
and Knaus, U. G.
(1996)
J. Biol. Chem.
271,
25746-25749 |
| 30. | Manser, E., Loo, T. H., Koh, C. G., Zhao, Z. S., Chen, X. Q., Tan, L., Tan, I., Leung, T., and Lim, L. (1998) Mol. Cell 1, 183-192[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Bagrodia, S.,
Taylor, S. J.,
Jordon, K. A.,
Van Aelst, L.,
and Cerione, R. A.
(1998)
J. Biol. Chem.
273,
23633-23636 |
| 32. |
Daniels, R. H.,
Zenke, F. T.,
and Bokoch, G. M.
(1999)
J. Biol. Chem.
274,
6047-6050 |
| 33. |
Ramer, S. W.,
and Davis, R. W.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
452-456 |
| 34. |
Leeuw, T.,
Fourest-Lieuvin, A.,
Wu, C.,
Chenevert, J.,
Clark, K.,
Whiteway, M.,
Thomas, D. Y.,
and Leberer, E.
(1995)
Science
270,
1210-1213 |
This article has been cited by other articles:
![]() |
C. F. Hughes and M. H. Perlin Differential expression of mepA, mepC and smtE during growth and development of Microbotryum violaceum Mycologia, May 1, 2005; 97(3): 605 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Winters and P. M. Pryciak Interaction with the SH3 Domain Protein Bem1 Regulates Signaling by the Saccharomyces cerevisiae p21-Activated Kinase Ste20 Mol. Cell. Biol., March 15, 2005; 25(6): 2177 - 2190. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamada, B. Duffy, J. A. Perry, and S. Kornbluth DNA replication checkpoint control of Wee1 stability by vertebrate Hsl7 J. Cell Biol., December 6, 2004; 167(5): 841 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hofmann, M. Shepelev, and J. Chernoff The genetics of Pak J. Cell Sci., September 1, 2004; 117(19): 4343 - 4354. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yang, Y. Qyang, G. Bartholomeusz, X. Zhou, and S. Marcus The Novel Rho GTPase-activating Protein Family Protein, Rga8, Provides a Potential Link between Cdc42/p21-activated Kinase and Rho Signaling Pathways in the Fission Yeast, Schizosaccharomyces pombe J. Biol. Chem., December 5, 2003; 278(49): 48821 - 48830. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohkuni, A. Okuda, and A. Kikuchi Yeast Nap1-Binding Protein Nbp2p Is Required for Mitotic Growth at High Temperatures and for Cell Wall Integrity Genetics, October 1, 2003; 165(2): 517 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kim, P. Yang, P. Catanuto, F. Verde, H. Lai, H. Du, F. Chang, and S. Marcus The Kelch Repeat Protein, Tea1, Is a Potential Substrate Target of the p21-activated Kinase, Shk1, in the Fission Yeast, Schizosaccharomyces pombe J. Biol. Chem., August 8, 2003; 278(32): 30074 - 30082. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jorgensen, B. Nelson, M. D. Robinson, Y. Chen, B. Andrews, M. Tyers, and C. Boone High-Resolution Genetic Mapping With Ordered Arrays of Saccharomyces cerevisiae Deletion Mutants Genetics, November 1, 2002; 162(3): 1091 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bao, Y. Qyang, P. Yang, H. Kim, H. Du, G. Bartholomeusz, J. Henkel, R. Pimental, F. Verde, and S. Marcus The Highly Conserved Protein Methyltransferase, Skb1, Is a Mediator of Hyperosmotic Stress Response in the Fission Yeast Schizosaccharomyces pombe J. Biol. Chem., April 27, 2001; 276(18): 14549 - 14552. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Bose, J. E. Irazoqui, J. J. Moskow, E. S. G. Bardes, T. R. Zyla, and D. J. Lew Assembly of Scaffold-mediated Complexes Containing Cdc42p, the Exchange Factor Cdc24p, and the Effector Cla4p Required for Cell Cycle-regulated Phosphorylation of Cdc24p J. Biol. Chem., March 2, 2001; 276(10): 7176 - 7186. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |